Sify -- Ahmedabad-based drug major Zydus Cadila today said that it has received approval from the US Food and Drug Administration (USFDA) to market two anti-hypertension drugs in the US market. These include Losartan Potassium tablets and Losartan Potassium plus Hydrochorothiazide tablets.
